These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15704157)

  • 1. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma.
    Aust DE; Haase M; Dobryden L; Markwarth A; Löhrs U; Wittekind C; Baretton GB; Tannapfel A
    Int J Cancer; 2005 Jul; 115(5):673-7. PubMed ID: 15704157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
    Nagasaka T; Sasamoto H; Notohara K; Cullings HM; Takeda M; Kimura K; Kambara T; MacPhee DG; Young J; Leggett BA; Jass JR; Tanaka N; Matsubara N
    J Clin Oncol; 2004 Nov; 22(22):4584-94. PubMed ID: 15542810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
    Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.
    Tannapfel A; Sommerer F; Benicke M; Katalinic A; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
    Gut; 2003 May; 52(5):706-12. PubMed ID: 12692057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
    Wu M; Semba S; Oue N; Ikehara N; Yasui W; Yokozaki H
    Gastric Cancer; 2004; 7(4):246-53. PubMed ID: 15616773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
    Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
    J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
    Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
    Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of BRAF and RAS are rare events in germ cell tumours.
    Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
    Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
    Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
    Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
    Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
    Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
    Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
    Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
    Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
    J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck.
    Weber A; Langhanki L; Sommerer F; Markwarth A; Wittekind C; Tannapfel A
    Oncogene; 2003 Jul; 22(30):4757-9. PubMed ID: 12879021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
    Li WQ; Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Iacopetta B
    Mol Cancer; 2006 Jan; 5():2. PubMed ID: 16403224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.